Aadi Bioscience Inc.

NASDAQ: AADI · Real-Time Price · USD
2.05
-0.05 (-2.38%)
At close: Mar 18, 2025, 3:59 PM

Aadi Bioscience Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
144.94M 227.57M 28.67M 30.54M 41.14M 53.78M 62.89M 68.8M 68.16M 34.05M 39.02M 134.81M 118.74M 129.85M 148.99M 161.38M 36.82M 39.01M
Short-Term Investments
32.26M 3.49M 18.57M 32.08M 37.43M 34.49M 45.96M 50.53M 66.73M 117.13M 133.54M 48.19M n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a 64K 64K 64K 64K 64K 64K 64K n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
2.14M 1.36M 1.4M 1.51M 1.56M 1.67M 1.8M 1.85M 1.89M 2M 2.11M 2.21M 2.29M 2.34M 2.21M 2.26M 20K 20K
Receivables
n/a n/a 5.9M 6.54M 5.92M 4.93M 5.49M 5.72M 3.68M 5.57M 1.86M 2.26M 2.06M 2.71M n/a n/a n/a 119.56K
Inventory
n/a n/a 5.31M 5.47M 6.1M 5.94M 6.43M 3.62M 3.46M 3.8M 1.86M 734K 727K 202K n/a n/a n/a n/a
Other Current Assets
1.47M 1.55M 2.84M 2.69M 2.42M 3.43M 3.83M 4.22M 2.9M 4.39M 3.75M 3.86M 2.81M 2.86M 2.28M 643K 578.46K 1.61M
Total Current Assets
178.67M 232.61M 61.29M 77.31M 93M 102.57M 124.59M 132.88M 144.92M 164.93M 180.03M 189.86M 124.33M 135.62M 151.27M 162.02M 37.39M 41M
Property-Plant & Equipment
9K 25K 7.63M 6.87M 6.99M 6.76M 5.97M 4.86M 4.35M 3.66M 2.03M 2.03M 2.01M 619K 614K 611K 9.45K 142.11K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.74M 3.81M 3.88M n/a n/a
Total Long-Term Assets
2.15M 1.39M 9.03M 8.38M 8.62M 8.5M 7.84M 6.78M 6.3M 5.72M 4.21M 4.24M 4.3M 6.7M 6.64M 6.75M 29.45K 162.11K
Total Assets
180.82M 234M 70.32M 85.7M 101.62M 111.07M 132.42M 139.66M 151.23M 170.65M 184.24M 194.1M 128.64M 142.32M 157.91M 168.77M 37.42M 41.16M
Account Payables
3.34M 3.66M 2.16M 1.37M 2.27M 3.1M 5.9M 2.6M 2.9M 6.51M 3.52M 3.92M 3.62M 4.01M 6.44M 5.21M 746.88K 458.66K
Deferred Revenue
n/a n/a n/a n/a -374K n/a n/a n/a n/a n/a n/a n/a -324K n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a 268K 322K n/a n/a n/a n/a 413K 404K n/a 374K 324K 163K n/a n/a 9.96K 39.17K
Other Current Liabilities
8.76M 524K -204K 928K 15.69M 13.29M 15.39M 11.85M 5.06M 6.63M 1.57M 8.19M 4.47M 6.2M n/a 5.69M 1.38M 1.54M
Total Current Liabilities
8.76M 12.27M 17.07M 15.81M 22.15M 19.88M 26.39M 20.52M 13M 17.75M 18.84M 17.89M 12.6M 11.51M 15.27M 11.57M 2.21M 2.13M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a 202K 393K n/a n/a n/a n/a 5.76M 5.76M 5.76M 5.76M 5.87M 5.76M 5.76M 5.76M n/a n/a
Total Long-Term Liabilities
n/a n/a 767K 1.02M 682K 738K 833K 946K 6.81M 6.92M 7.02M 7.1M 7.31M 6.18M 6.23M 6.28M n/a n/a
Total Liabilities
8.76M 12.27M 17.84M 16.83M 22.83M 20.61M 27.23M 21.46M 19.81M 24.67M 25.86M 25M 19.91M 17.69M 21.5M 17.85M 2.21M 2.13M
Total Debt
n/a n/a 833K 946K 1.06M 6.92M 7.02M 1.37M 1.47M 1.57M 1.66M 1.72M 1.77M 587K 605K 613K 9.96K 39.17K
Common Stock
4K 4K 2K 2K 2K 2K 2K 2K 2K 2K 2K 2K 2K 2K 2K 2K 4.75K 4.74K
Retained Earnings
-312.25M -259.64M -332.65M -314.38M -301.83M -287.25M -268.96M -252.69M -236.39M -218.42M -203.2M -189.28M -174.81M -156.54M -142.69M -126.69M -155.4M -150.99M
Comprehensive Income
9K 1K 16K 39K -27K -8K 27K -16K -44K -32K -115K -99K 0.00 n/a n/a n/a -5.54K -0.00
Shareholders Equity
172.07M 221.73M 52.48M 68.87M 78.79M 90.46M 105.19M 118.2M 131.42M 145.99M 158.38M 169.11M 108.73M 124.63M 136.41M 150.93M 35.22M 39.03M
Total Investments
n/a 3.49M 18.57M 32.08M 37.43M 34.55M 46.02M 50.53M 66.73M 117.13M 133.54M 48.19M n/a n/a n/a n/a n/a n/a